Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: A comparison with clinically localized prostate cancer

Asian Journal of Andrology

Volumn 15, Issue 2, 2013, Pages 241-245

  Yao, Xu Dong ^a   Liu, Xiao Jun ^a   Zhang, Shi Lin ^a   Dai, Bo ^a   Zhang, Hai Liang ^a   Ye, Ding Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

clinically localized prostate cancer; complications; locally advanced prostate cancer; prostate cancer (PCa); prostatectomy; radical retropubic prostatectomy (RRP)

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; BLOOD VOLUME; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; DEEP VEIN THROMBOSIS; HUMAN; INCIDENCE; INCONTINENCE; KIDNEY INJURY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; RECTUM INJURY; URETER INJURY;

AGED; HUMANS; LYMPHEDEMA; MALE; MIDDLE AGED; NEOPLASM STAGING; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84874628316     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.120     Document Type: Article

References (39)

1. Moore AL, Dimitropoulou P, Lane A, Powell PH, Greenberg DC et al. Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. BJU Int 2009; 104: 1592-8.
2. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB et al. EAU guidelines on prostate cancer. Arnhem: European Association of Urology; 2010 [updated 2010]. http://www.uroweb.org/guidelines/online-guidelines/
3. Ham WS, Park SY, Rha KH, Kim WT, Choi YD. Robotic radical prostatectomy for patients with locally advanced prostate cancer is feasible: results of a singleinstitution study. J Laparoendosc Adv Surg Tech A 2009; 19: 329-32.
4. Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol 2007; 177: 932-6.
5. Stratton KL, Chang SS. Locally advanced prostate cancer: the role of surgical management. BJU Int 2009; 104: 449-54.
6. Valicenti RK. The management of locally advanced prostate cancer. Prostate Cancer Prostatic Dis 2002; 5: 8-11.
7. Carver BS, Bianco FJ, Scardino PT, Eastham JA. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. JUrol 2006; 176: 564-8.
8. Gray PG, Shipley WU. The importance of combined radiation and endocrine therapy in locally advanced prostate cancer. Asian J Androl 2012; 14: 245-6.
9. Xylinas E, Dache A, Roupret M. Is radical prostatectomy a viable therapeutic option in clinically locally advanced (cT3) prostate cancer? BJU Int 2010; 106: 1596-600.
10. NCI.Prostate Cancer treatment: stage III prostate cancer. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/ page8 (accessed April 2009).
11. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB et al. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 68-80.
12. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005; 95: 751.
13. Lerner SE, Blute ML, Zincke H. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 1995; 154: 1447-52.
14. Rocco B, Jereczek-Fossa BA, Matei DV, Verweij F, Santoro L et al. Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis. BJU Int 2009; 104: 1624-30.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-83.
16. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 492-7.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications-a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
18. Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A et al. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. J Urol 2007; 178: 493-9.
19. Namiki M, Konaka H. What is appropriate neoadjuvant/adjuvant androgen deprivation for high-risk/locally advanced prostate cancer? Asian J Androl 2011; 13: 624-5.
20. Payne H. Management of locally advanced prostate cancer. Asian J Androl 2009; 11: 81-7.
21. Payne HA, Gillatt DA. Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK. BJU Int 2007; 99: 545-53.
22. Oh WK, Kantoff PW. Treatment of locally advanced prostate cancer: is chemotherapy the next step? J Clin Oncol 1999; 17: 3664-75.
23. UICC. TNM Classification of Malignant Tumours. 4th edn, 2nd revision. New York/Berlin/Heidelberg: Springer; 1992.
24. Wirth MP, Hakenberg OW, Froehner M. Optimal treatment of locally advanced prostate cancer. World J Urol 2007; 25: 169-76.
25. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomized phase III trial. Lancet 2009; 373: 301-8.
26. Swanson GP. Management of locally advanced prostate cancer: past, present, future. J Urol 2006; 176: 34-41.
27. Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC. Radical prostatectomy for clinical stage T3a disease. Cancer 2007; 109: 1273-8.
28. Montie JE. Initial therapy with radical prostatectomy for high-risk localized prostate cancer. J Urol 2006; 176: 27-9.
29. Hisasue S, Takahashi A, Kato R, Shimizu T, Masumori N et al. Early and late complications of radical retropubic prostatectomy: experience in a single institution. Jpn J Clin Oncol 2004; 34: 274-9.
30. Carvalhal GF, Griffin CR, Kan DH, Loeb S, Catalona WJ. Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures. BJU Int 2009; 105: 1650-3.
31. Löppenberg B, Noldus J, Holz A, Palisaar RJ. Reporting complications after open radical retropubic prostatectomy using the Martin Criteria. J Urol 2010; 184: 944-8.
32. Dillioglugil O, Leibman BD, Leibman NS, Kattan MW, Rosas AL et al. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 1997; 157: 1760-7.
33. Lepor H, Nieder AM, Ferrandino MN. Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol 2001; 166: 1729-33.
34. Dafnis G, Wang YH, Borck L. Transsphincteric repair of rectourethral fistulas following laparoscopic radical prostatectomy. Int J Urol 2004; 11: 1047-9.
35. Shekarriz B, Upadhyay J, Wood DP. Intraoperative, perioperative, and long-term complications of radical prostatectomy. Urol Clin N Am 2001; 28: 639-53.
36. Son-Fat H, Hio-Fai L, Kin L, Men-Kin T. Clinical results of radical prostatectomy for patients with prostate cancer in Macau. Chin Med J 2008; 121: 295-8.
37. Loeb S, Smith ND, Roehl KA, Catalona WJ. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology 2007; 69: 1170-5.
38. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol 2008; 179: 40-4.
39. Audenet F, Comperat E, Seringe E, Drouin SJ, Richard F et al. Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score o8: a single-center experience. Urol Oncol 2011; 29; 602-7.